In this study, we demonstrate that EVs released from cells expressing SARS‐CoV‐2 spike protein can incorporate full‐length spike and serve as decoy targets for neutralizing antibodies (nAbs) in convalescent patient sera, reducing the efficiency of nAbs at preventing viral infection. Here, PROS1 is linked to viral infectious disease.